250 related articles for article (PubMed ID: 7545390)
1. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.
van der Voort R; Manten-Horst E; Smit L; Ostermann E; van den Berg F; Pals ST
Biochem Biophys Res Commun; 1995 Sep; 214(1):137-44. PubMed ID: 7545390
[TBL] [Abstract][Full Text] [Related]
2. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
3. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
Dougherty GJ; Cooper DL; Memory JF; Chiu RK
J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
[TBL] [Abstract][Full Text] [Related]
5. Adhesive interactions between alternatively spliced CD44 isoforms.
Droll A; Dougherty ST; Chiu RK; Dirks JF; McBride WH; Cooper DL; Dougherty GJ
J Biol Chem; 1995 May; 270(19):11567-73. PubMed ID: 7538117
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
[TBL] [Abstract][Full Text] [Related]
8. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
9. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
[TBL] [Abstract][Full Text] [Related]
10. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
Lokeshwar VB; Fregien N; Bourguignon LY
J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
[TBL] [Abstract][Full Text] [Related]
11. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
Yang B; Yang BL; Savani RC; Turley EA
EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
[TBL] [Abstract][Full Text] [Related]
12. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
Lesley J; English N; Perschl A; Gregoroff J; Hyman R
J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
[TBL] [Abstract][Full Text] [Related]
13. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
[TBL] [Abstract][Full Text] [Related]
14. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
[TBL] [Abstract][Full Text] [Related]
15. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
17. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system.
Aho R; Jalkanen S; Kalimo H
J Neuropathol Exp Neurol; 1994 May; 53(3):295-302. PubMed ID: 7513749
[TBL] [Abstract][Full Text] [Related]
18. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
19. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin.
Aho R; Kalimo H; Salmi M; Smith D; Jalkanen S
J Neuropathol Exp Neurol; 1997 May; 56(5):557-68. PubMed ID: 9143269
[TBL] [Abstract][Full Text] [Related]
20. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Calikoglu E; Augsburger E; Chavaz P; Saurat JH; Kaya G
J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]